New Aseptic API Line Facility
AMRI Celebrates Grand Opening of New State-of-the-Art aseptic API line facility in Valladolid Spain
AMRI, a global contract research, development and manufacturing organization working with the life sciences industry to improve patient outcomes and quality of life for more than 25 years, celebrates the debut of its new multipurpose aseptic API line facility at the company’s location in Valladolid, Spain. The aseptic API line facility, which was officially opened today by AMRI leaders and local officials, was announced in November 2017 and enhances capacity at the site while complementing AMRI’s other aseptic API manufacturing plants in Bon Encontre and Tonneins, France.
This investment – coupled with the build-out of analytical services and a new warehouse, provides additional capacity, technology and expertise to serve customers’ increasing demand for sterile API. It also supports AMRI’s commitment to growth in the region.
“We continue to see an increase in interest in our sterile capabilities and are ready to support increasing demand,” said Michael J. Mulhern, chief executive officer of AMRI. “By adding critical analytical services, we are well-positioned to help customers accelerate the pace of their product development while ensuring their performance and quality.”
Aseptic API Line Facility meets strict design protocols to ensure safety
AMRI’s aseptic API line facility are designed to meet requirements from pilot-scale to multi-ton scale manufacturing, and the company’s sterilization capability can be integrated with API production or operate as a separate outsourced step for customers who do not have bulk sterile facilities or who may need additional capacity. Further integration is offered with AMRI’s Drug Product capabilities.
The grand opening was celebrated with an inaugural ceremony attended by AMRI leaders and notable guests.
“We would like to thank the region of Castilla y León for their generosity and continued support,” said Mulhern. “There is a talented scientific and engineering workforce in the region and we are happy to reaffirm our commitment to the region and the expansion of our capabilities and expertise to customers in Europe.”
About Albany Molecular Research Inc. (AMRI)
Scientific Expertise. Market-Leading Technology. Best-in-Class Solutions.
AMRI, a global contract research and manufacturing organization, partners with the pharmaceutical and biotechnology industries to improve patient outcomes and quality of life. With locations in North America, Europe and Asia, AMRI’s team combines scientific expertise and market-leading technology to provide a complete suite of solutions in Discovery, Development, Analytical Services, API Manufacturing and Drug Product. We’ve got it down to an exact science.
We care about the quality and success of your projects as if they were our own. No matter the size of your project or the complexity of the challenge, our experts pinpoint and execute the precise solution to hit your target. From molecule to molecule, batch to batch, your product will benefit from our ingenuity.
